Osteoclasts and biomaterials

European Journal of Trauma

Volumn 32, Issue 2, 2006, Pages 107-113

  Schilling, Arndt F ^a,b   Filke, Sandra ^a   Brink, Silja ^a   Korbmacher, Heike ^a   Amling, Michael ^a   Rueger, Johannes M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b University of Medical School Hamburg Eppendorf   (Germany)

Author keywords

Biomaterial; Implant; Osteoclast; Particle; Resorption

Indexed keywords

BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE;

ALBERS SCHOENBERG DISEASE; BIODEGRADABLE IMPLANT; BONE GRAFT; BONE METASTASIS; CELL INTERACTION; CYTOLOGY; HEALING; HUMAN; IMPLANT; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PARTICULATE MATTER; POSTMENOPAUSE OSTEOPOROSIS; PROSTHESIS MATERIAL; REVIEW;

EID: 33746434093     PISSN: 14390590     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00068-006-6043-1     Document Type: Review

References (66)

1. Schwartz Z, Weesner T, van Dijk S, et al. Ability of deproteinized cancellous bovine bone to induce new bone formation. J Periodontol 2000;71:1258-69.
2. Rueger JM. Bone substitution materials. Current status and prospects. Orthopadeics 1998;27:72-9.
3. Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 1969;3:211-37.
4. Corral DA, Amling M, Priemel M, et al. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci USA 1998;95:13835-40.
5. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
6. Amling M, Pogoda P, Beil FT, et al. Central control of bone mass: brainstorming of the skeleton. Adv Exp Med Biol 1902;496:85-94.
7. Kondo H, Nifuji A, Takeda S, et al. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem 2005;280:30192-200.
8. Ruff C, Holt B, Trinkaus E. Who's afraid of the big bad Wolff? "Wolff's law" and bone functional adaptation. Am J Phys Anthropol 2006 (in press).
9. Eriksen EF, Langdahl B, Vesterby A, et al. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. J Bone Miner Res 1999;14:1217-21.
10. Hsieh PH, et al. Periprosthetic fractures of the greater trochanter through osteolytic cysts with uncemented MicroStructured Omnifit prosthesis: retrospective analyses pf 23 fractures in 887 hips after 5-14 years. Acta Orthop 2005;76:538-43.
11. Rodrigues P, Hering F, Campagnari JC. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients. Prostate Cancer Prostatic Dis 2004;7:350-4.
12. Heider U, Hofbauer LC, Zavrski I, et al. Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease. Biochem Biophys Res Commun 2005;338:687-93.
13. Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med 2003;52:1-7.
14. Mohn A, Capanna R, Delli PC, et al. Autosomal malignant osteopetrosis. From diagnosis to therapy. Minerva Pediatr 2004;56:115-8.
15. Horton MA, Dorey EL, Nesbitt SA, et al. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J Bone Miner Res 1993;8:239-47.
16. Amling M, Delling G. Cell biology of osteoclasts and molecular mechanisms of bone resorption. Pathologe 1996;17:358-67.
17. Soriano P, et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
18. Tanaka S, Amling M, Neff L, et al. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 1996;383:528-31.
19. Frattini A, Orchard PJ, Sobacchi C, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000;25:343-6.
20. Banco R, et al. Rickets and osteopetrosis: the osteosclerotic (oc) mouse. Clin Orthop Relat Res 1985;238-246.
21. Kornak U, Kasper D, Bösel MR, et al. Loss of the CIC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man. Cell 2001;104:205-15.
22. Saftig P, Hunziker E, Wehmeyer O, et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 1998;95:13453-8.
23. Minkin C, Marinho VC. Role of the osteoclast at the bone-implant interface. Adv Dent Res 1999;13:49-56.
24. Stenbeck G, Horton MA. Endocytic trafficking in actively resorbing osteoclasts. J Cell Sci 2004;117:827-36.
25. Gerdhem P, Ivaska KK, Alatalo SL, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004;19:386-93.
26. Helfrich MH. Osteoclast diseases and dental abnormalities. Arch Oral Biol 2005;50:115-22.
27. Amling M, Neff L, Priemel M, et al. Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone 2000;27:603-10.
28. Chen CJ, Lee MY, Hsu ML, et al. Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report. Ann Hematol 2003;82:64-7.
29. Kocher MS, Kasser JR. Osteopetrosis. Am J Ort hop 2003;32:222-8.
30. Stanford RE, et al. Multiaxial pedicle screw designs: static and dynamic mechanical testing. Spine 2004;29:367-75.
31. Yamaguchi K, et al. Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty. J Orthop Sci 2005;10:32-6.
32. Soininvaara TA, Jurvelin JS, Miettinen HJ, et al. Effect of alendronateon periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int 2002;71:472-7.
33. DeHeer DH, Engels JA, DeVries AS, et al. In situ complement activation by polyethylene wear debris. J Biomed Mater Res 2001;54:12-9.
34. Sabokbar A, et al. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis 1998;57:614-8.
35. Sommer B, Felix R, Sprecher C, et al. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro. J Biomed Mater Res A 2005;72:67-76.
36. von Knoch F, Heckelei A, Wedemeyer C, et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 2005;75:288-94.
37. Schindeler A, Little DG. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Biochem Biophys Res Commun 2005;338:710-6.
38. von Knoch F, Heckelei A, Wedemeyer C, et al. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005;26:3549-55.
39. Markiewicz MR, et al. Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge. J Am Dent Assoc 2005;136:1669-74.
40. Murray DW, Rushton N. Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg Br 1990;72:988-92.
41. Sabokbar A, Fujikawa Y, Brett J, et al. Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor. Acta Orthop Scand 1996;67:593-8.
42. Sun JS, Lin FH, Hung TY, et al. The influence of hydroxyapatite particles on osteoclast cell activities. J Biomed Mater Res 1999;45:311-21.
43. Kim KJ, et al. Activation of osteoclast-mediated bone resorption by the supernatant from a rabbit synovial cell line in response to polyethylene particles. J Biomed Mater Res 1996;32:3-9.
44. Bi Y, Seabold JM, Kaar SG, et al. Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 2001;16:2082-91.
45. Childs LM, et al. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338-47.
46. Allen M, Butter R, Chandra L, et al. Toxicity of particulate silicon carbide for macrophages, fibroblasts and osteoblast-like cells in vitro. Biomed Mater Eng 1995;5:151-9.
47. Hirayama T, et al. Effect of particle size on macrophage-osteoclast differentiation in vitro. J Orthop Sci 2001;6:53-8.
48. Vogel M, Voigt C, Knabe C, et al. Development of multinuclear giant cells during the degradation of Bioglass particles in rabbits. J Biomed Mater Res A 2004;70:370-9.
49. Marchisio M, Di Carmine M, Pagone R, et al. Implant surface roughness influences osteoclast proliferation and differentiation. J Biomed Mater Res B Appl Biomater 2005;75:251-6.
50. Gomi K, et al. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. Biomaterials 1993;14:91-6.
51. Jones SJ, Boyde A, Ali NN. The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts. Anat Embryol (Berl) 1984;170:247-56.
52. Leeuwenburgh S, Layrolle P, Barrere F, et al. Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro. J Biomed Mater Res 2001;56:208-15.
53. Benghuzzi H, et al. Bioceramics surface modification by means of osteoclasts in culture. Biomed Sci Instrum 1999;35:321-6.
54. Zheng Q, Du J, Xia Z, et al. Biodegradation of tricalcium phosphate ceramics by osteoclasts. J Tongji Med Univ 1998;18:257-61.
55. Monchau F, Lefevre A, Descamps M, et al. In vitro studies of human and rat osteoclast activity on hydroxyapatite, beta-tricalcium phosphate, calcium carbonate. Biomol Eng 2002;19:143-52.
56. Matsuoka H, Nakamura T, Takadama H, et al. Osteoclastic resorption of bone-like apatite formed on a plastic disk as an in vitro assay system. J Biomed Mater Res 1998;42:278-85.
57. Taylor JC, Cuff SE, Leger JP, et al. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentations pilot study. Int J Oral Maxillofac Implants 2002;17:321-30.
58. Muller-Mai CM, et al. Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface. J Biomed Mater Res 1995;29:9-18.
59. Lambrecht JT. Cell cultures of human osteoclasts for testing biomaterials. Dtsch Zahnarztl Z 1990;45:82-6.
60. Schilling AF, Linhart W, Filke S, et al. Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 2004;25:3963-72.
61. Siebers MC, Matsuzaka K, Walboomers XF, et al. Osteoclastic resorption of calcium phosphate coatings applied with electrostatic spray deposition (ESD), in vitro. J Biomed Mater Res A 2005;74:570-80.
62. Yamada S, et al. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios. Biomaterials 1997;18:1037-41.
63. Kamijou T, Nakajima T, Ozawa H. Effects of osteocytes on osteo-induction in the autogenous rib graft in the rat mandible. Bone 1994;15:629-37.
64. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005;11:76-81.
65. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.
66. Stevens MM, Marini RP, Schaefer D, et al. In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci USA 2005;102:11450-5.